Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B

American Journal of Gastroenterology

Volumn 91, Issue 11, 1996, Pages 2323-2328

  Hayashi, Paul H ^b   Beames, Mark P ^b   Kuhns, Mary C ^b   Hoofnagle, Jay H ^a   Di Bisceglie, Adrian M ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; DNA POLYMERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT ALPHA2B INTERFERON; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; HEPATITIS B; HUMAN; MICROPARTICLE ENZYME IMMUNOASSAY; PATIENT MONITORING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN M; INTERFERON ALFA-2B; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 0029806124     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Marinos G, Smith HM, Naoumov NV, et al. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection. Hepatology 1994;19: 303-11.
2. Perrillo R, Mimms L, Schechtman K, et al. Monitoring of antiviral therapy with quantitative evaluation of HBeAg: A comparison with HBV DNA testing. Hepatology 1993;18:1306-12.
3. Feinman SV, Overby LR, Berris B, et al. The significance of IgM antibodies to hepatitis B core antigen in hepatitis B carriers and hepatitis B-associated chronic liver disease. Hepatology 1982;2:795-9.
4. Banniger P, Altorfer J, Frosner GG, et al. Prevalence and significance of anti-HBc IgM (radioimmunoassay) in acute and chronic hepatitis B and in blood donors. Hepatology 1983;3:337-42.
5. Sjogren M, Hoofnagle JH. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Gastroenterology 1985;89:252-8.
6. Surrenti C, Ambu S, Patussi V, et al. Diagnostic significance of anti-HBc IgM (RIA) in healthy HBsAg carriers and chronic hepatitis B. J Med Virol 1986;18:229-34.
7. Gerlich WH, Uy A, Lambrecht F, et al. Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol 1986; 24:288-93.
8. Eble K, Clemens J, Krenc C, et al. Differential diagnosis of acute viral hepatitis using rapid, fully automated immunoassays. J Med Virol 1991;33:139-50.
9. Di Bisceglie AM, Fong TL, Fried MW, et al. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B. Am J Gastroenterol 1993;88:1887-92.
10. Kaplan PM, Greenman RL, Gerin JL, et al. DNA polymerase associated with human hepatitis B antigen. J Virol 1973;12:995-1005.
11. Chau ICH, Hargie MP, Decker RH, et al. Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc. Hepatology 1983;3:142-9.
12. Hadziyannis SJ, Hadziyannis AS, Dourakis S, et al. Clinical significance of quantitative anti-HBc IgM assay in acute and chronic HBV infection. Hepatogastroenterology 1993;40:588-92.
13. Smith HM, Lau JYN, Davies SE, et al. Significance of serum IgM anti-HBc in chronic hepatitis B virus infection. J Med Virol 1992;36: 16-20.
14. Brunetto MR, Cerenzia MT, Oliveri F, et al. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 1993;19:431-6.
15. Mels GC, Bellati G, Leandro G, et al. Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 1994;14:175-81.